Skip to content

National Agency for Medicines and Medical Devices

Search for:

HOME
ABOUT THE INSTITUTION
INFORMATION FOR THE PUBLIC
CONTACT
RO

In-use surveillance

Specific legislation

LAW no. 95/2006 on healthcare reform, republished as amended, Article 933
Article 935
Article 933
Article 936

Agency

> Programmes and strategies
> Activity reports
> Informative Bulletin
> Press releases
> FAQ
> Counterfeiting
> Facebook

Medicines for human use

> Important notifications – Medicines for human use
> Legislation – Medicines for human use
> Forms and tariffs – Medicines for human use
> Medicinal product authorisation
> Parallel import authorisation
> Health technologies assessment
> Clinical trials
> Last resort treatments
> Pharmacovigilance
> Report an adverse reaction
> Direct healthcare professionals communications
> Submit a medicinal product quality complaint
> Inform on medicinal product shortage
> Medicinal products under additional monitoring
> Pharmaceutical inspection
> Advertising
> Readability
> Standard terms
> Intra-Community deliveries notifications
> Drug discontinuity notifications
> Sponsorships – Medicinal products for human use
> Index of medicinal products for human use

Medical Devices

> Important notifications – Medical Devices
> Legislation – Medical Devices
> Forms and fees – Medical Devices
> European regulations on medical devices
> CE marking
> Definitions and classification of medical devices
> Registration of medical devices into the national database
> Grant of customs notice
> Grant of donation notice
> Grant of out-of-scope notice
> Vigilance
> Market surveillance
> In-use surveillance
> Clinical investigation
> Notified bodies
> Operation notice
> Record of EU/EEA service providers into the database
> Grant of notice for use
> Grant of periodic check bulletin
> Report an incident
> Sponsorships – Medical Devices

Search the site

Search for:

Copyright © 2017 NAMMD

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.I agree Read more